PTC Upsizes Shares, Prices in Range in $125.6M IPO
A month after filing for an initial public offering (IPO), PTC Therapeutics Inc. priced the offering, upsizing to 8.4 million shares at $15 apiece, above the midpoint of its proposed range of $13 to $16 per share, for a $125.6 million haul. The company granted underwriters the option to purchase up to 1.26 million additional shares at the offering price, potentially garnering another $18.8 million.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST